Powered by
-
BMY Stock Chart
Historical BMY Prices
Bristol-Myers Squibb Stock Analysis
Rating: Buy
Total Grade: B
Analysis Breakdown
| BMY Stock Grade: | B |
| Fundamental Grade: | C |
| Quantitative Grade: | B |
| BMY Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | D |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| BMY Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | D |
| Cash Flow: | B |
| Return on Equity: | A |
Bristol-Myers Squibb Stock: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | C |
BMY Stock predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
-
Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings Visibility - October 20, 2017
Bristol-Myers Squibb Co (NYSE:BMY) is a constituent of the 135 company Pharmaceuticals GICS industry group, which is part of the 783 company GICS Health Care sector. BMY's market value is $107.1 billion which falls in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 32 among the 135 companies in this industry group, giving it a well above-average position; in the top half of the sector with a ranking of 225 among the 783 companies in the sector, and number 1,631 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Catch This Falling Knife — Go Long Celgene Corporation - October 20, 2017
Pharma stock falling knives are the scariest to catch. But this reaction to the Celgene headline is overdone. Catch CELG but with caution. Continue…
-
Bristol-Myers Squibb Co (BMY) Stock Raised to Hold - October 6, 2017
Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The shares have been upgraded from a Sell to a Hold in the last week. Continue…
-
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear - September 18, 2017
BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support. Continue…
-
3 Blue-Chip Stocks to Buy Before They Get Hot - August 25, 2017
These three blue-chip stocks are ready for a comeback. It's time to consider buying them now before Wall Street wises up. Continue…
-
3 Big Stock Charts for Tuesday: Bristol-Myers Squibb Co (BMY), United Parcel Service, Inc. (UPS) and Intuit Inc. (INTU) - August 15, 2017
Bristol-Myers Squibb (BMY), United Parcel Service (UPS) and Intuit (INTU) all broke through their respective top Bollinger Bands on Monday. Continue…
-
Why AstraZeneca plc (ADR) (AZN), Advanced Micro Devices, Inc. (AMD) and Spirit Airlines Incorporated (SAVE) Are 3 of Today’s Worst Stocks - July 27, 2017
Advanced Micro Devices (AMD), AstraZeneca (AZN) and Spirit Airlines (SAVE) never even had a prayer of bullish progress on Thursday. Continue…
-
Why Bristol-Myers Squibb Co (BMY) Shares Are Sinking Today - July 27, 2017
Bristol-Myers Squibb (BMY) stock took a hit today after AstraZeneca (AZN) reported a failed drug test, despite its positive earnings report. Continue…
-
Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally - July 27, 2017
GILD stock fell long enough that its P/E is now under 8. This is value I can bank on, and this Gilead play can make you money too. Continue…
-
7 Stocks to Buy in July - July 5, 2017
With Independence Day gone, traders should look to historically strong stocks during July, such as consumer staples, utilities and healthcare stocks. Continue…
